Pasar al contenido principal

DISEMINACION DEL VIRUS HERPES SIMPLEX TIPO 1 EN OLIGODENDROCITOS HUMANOS: PAPEL DE LA AUTOFAGIA Y DEL PROTEOLIPIDO MAL

PID2022-140632NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pseudorabies virus uses clathrin mediated endocytosis to enter PK15 swine cell line

  • Andreu, Sabina
  • Agúndez, Carmen
  • Ripa, Inés
  • López-Guerrero, José Antonio
  • Bello-Morales, Raquel
Pseudorabies virus (PRV), a herpesvirus responsible for Aujeszky’s disease, causes high mortality in swine populations. To develop effective and novel antiviral strategies, it is essential to understand the mechanism of entry used by PRV to infect its host. Viruses have different ways of entering host cells. Among others, they can use endocytosis, a fundamental cellular process by which substances from the external environment are internalized into the cell. This process is classified into clathrin-mediated endocytosis (CME) and clathrin-independent endocytosis (CIE), depending on the role of clathrin. Although the involvement of cholesterol-rich lipid rafts in the entry of PRV has already been described, the importance of other endocytic pathways involving clathrin remains unexplored to date. Here, we characterize the role of CME in PRV entry into the PK15 swine cell line. By using CME inhibitory drugs, we report a decrease in PRV infection when the CME pathway is blocked. We also perform the shRNA knockdown of the μ-subunit of the adaptor protein AP-2 (AP2M1), which plays an important role in the maturation of clathrin-coated vesicles, and the infection is greatly reduced when this subunit is knocked down. Furthermore, transmission electron microscopy images report PRV virions inside clathrin-coated vesicles. Overall, this study suggests for the first time that CME is a mechanism used by PRV to enter PK15 cells and provides valuable insights into its possible routes of entry., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación, grant number PID2022-140632NB-I00). The funders had no role in study design, data collection, analysis, publishing decisions, or manuscript preparation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polyclonal LC3B Antibodies Generate Non-Specific Staining in the Nucleus of Herpes Simplex Virus Type 1-Infected Cells: Caution in the Interpretation of LC3 Staining in the Immunofluorescence Analysis of Viral Infections

  • Ripa, Inés
  • Andreu, Sabina
  • Galdo, Daniel
  • Caballero, Oliver
  • Bello Morales, Raquel
  • López Guerrero, José Antonio
The most common marker used to monitor autophagy is the microtubule-associated protein light chain 3 (LC3). Upon induction of autophagy, LC3 is conjugated to phosphatidylethanolamine and targeted to autophagic membranes, which can be easily detected by immunofluorescence. However, this technique has some limitations. During the early stages of HSV-1 infection, strong LC3B nuclear staining is observed within the viral replication compartments. This staining is only detected when using polyclonal antibodies. It is noteworthy that monoclonal antibodies or the GFP-LC3 plasmid do not reveal any nuclear LC3 staining. Interestingly, LC3B is not detected in the nuclear fraction of infected cells by Western blotting, even when polyclonal antibodies are used. In infected LC3B knockout cells, nuclear staining is still observed when using polyclonal LC3B antibodies. This suggests that polyclonal LC3B antibodies generate non-specific nuclear staining in infected cells, which could result in misinterpretation and erroneous conclusions. These findings raise questions about the reliability of LC3-immunofluorescence assays in herpesvirus infections. It is imperative that the methodology employed for monitoring autophagy by immunofluorescence in viral infections be reviewed and updated, and that the specificity of anti-LC3B antibodies be tested before use. To ensure the accuracy of the results, it is essential to validate this technique with additional assays, such as by immunoblot analysis or via the use of autophagy-deficient cell lines., This research was funded by the Ministerio de Ciencia e Innovación, Spain (PID2022-140632NB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of a Baloxavir-Inspired Endonuclease Inhibitor That Prevents Herpes Simplex Virus 1 Replication in Cell Culture and In Vivo

  • Andreu, Sabina
  • Tang, Kai
  • Zhou, Jiahui
  • Pino-Peco, Gabriel
  • López-Carrobles, Nerea
  • Bello-Morales, Raquel
  • Galdo-Torres, Daniel
  • Zhang, Lina
  • Gago, Federico
  • López-Guerrero, José Antonio
  • Liu, Xinyong
  • Zhan, Peng
  • Menéndez-Arias, Luis
Herpes simplex viruses (HSV-1 and HSV-2) are highly prevalent and contagious, causing lifelong infections that cannot be eradicated with current therapies. Acyclovir and other viral DNA polymerase inhibitors are effective antiviral agents for treating HSV infections. However, despite the recent approval of pritelivir and amenamevir (helicase–primase complex inhibitors), drug resistance is still a major threat to therapeutic success. This research focuses on developing new antiviral strategies against HSV-1 by targeting the pUL15 endonuclease, a component of the viral packaging motor/terminase complex, using substituted polycyclic pyridones derived from baloxavir acid. Several compounds display low micromolar IC values in enzymatic assays. Among them, the prioritized compound, LN-7, shows a 50% effective concentration (EC) of 2.8 ± 1.1 µm in antiviral assays and favorable pharmacokinetic properties in rats. LN-7 demonstrates antiviral efficacy in infected mice, while exhibiting fewer clinical signs compared to controls. Overall, LN-7 emerges as a promising lead for treating herpesvirus infections and is therefore a first-in-class drug candidate targeting HSV genome packaging., Work at the CBM was supported in partby the Ministry of Science, Innovation and Universities of Spain throughGrant No. PID2022-136725OB-I00/AEI/10.13039/501100011033 awardedto L.M.-A. An institutional grant of the Fundación Ramón Areces to theCBM is also acknowledged. The CBM has been certified since 2023 asSevero Ochoa Center of Excellence by AEI/MCI/10.13039/501100011033.L.M.-A. is member of the Global Virus Network. Work at the Au-tonomous University of Madrid and the University of Alcalá was sup-ported by grants of the Ministry of Science, Innovation and Uni-versities of Spain awarded to F.G. (Grant No. PID2022-136307OB-C22/AEI/10.13039/501100011033) and J.A.L.-G. (Grant No. PID2022-140632NB-I00/AEI/10.13039/501100011033). PID2022 grants were alsofunded by the FEDER “A way to make Europe”. Work at Shandong Univer-sity was supported by the Key Research and Development Program, Min-istry of Science and Technology of the People’s Republic of China (GrantNo. 2023YFC2606500 awarded to P.Z.), the Shandong Laboratory ProgramGrant No. SYS202205 (awarded to X.L.), the Shandong Provincial NaturalScience Foundation Grant No. ZR2024QH201 (awarded to K.T.), and thePostdoctoral Fellowship Program of the China Postdoctoral Science Foun-dation (Grant Nos. GZC20231489 and 2023M742101 awarded to K.T.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From HSV-2 to HSV-1: A change in the epidemiology of genital herpes

  • Andreu, Sabina
  • Galdo-Torres, Daniel
  • Ripa, Inés
  • Caballero, Oliver
  • Bello-Morales, Raquel
  • López-Guerrero, José Antonio
Genital herpes (GH), historically associated with herpes simplex virus type 2 (HSV-2), is changing its etiology. Since the last few decades, there has been an increase in genital infections caused by herpes simplex virus type 1 (HSV-1). In fact, in several countries, preferably in high-income regions such as North America or Western Europe, HSV-1 has become the leading cause of first-episode GH, especially among adolescents and young adults. However, the epidemiological trend varies geographically, with slower changes observed in Africa, Latin America, and Southeast Asia, where GH HSV-2 remains dominant. This epidemiological shift may be mainly due to the decline in HSV-1 seroprevalence, decreased childhood exposure to the virus, and changes in sexual practices. Despite the global decline in HSV-1 seroprevalence, GH caused by HSV-1 is rising by 1-2% annually in many areas. This review summarizes the seroprevalence of HSV-1/-2 worldwide in recent decades and discusses the changes in GH etiology and contributing factors. Despite the substantial global burden of the disease and its psychosocial impact, no vaccine or curative treatment exists. Active surveillance, health and sexual health education, and targeted interventions are vital to manage this changing landscape and to mitigate the public health issue posed by GH and HSV-1., This research was funded by Ministerio de Ciencia e Innovación, Spain, grant number PID2022-140632NB-I00.